Rivaroxaban for treating chronic heart failure [ID1462]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction [ID3912 ]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ambulatory pulmonary artery pressure monitoring devicesStatus:Awaiting developmentProgramme:Diagnostics guidanceExpected publication date: TBC
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Virtual Wards for Heart FailureStatus:Awaiting developmentProgramme:Medical technologies guidanceExpected publication date: TBC